Drug Trial Radar · NCT05731843
Drug-drug Interaction Study of Ruzasvir and Bemnifosbuvir
Last checked: Nov 20, 2026Latest source record: Jun 1, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
32
Actual
Start
Jan 30, 2023
Primary completion
Mar 15, 2023
Study completion Mar 15, 2023
Sponsor
- Lead sponsor
- Atea Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Feb 16, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Drug-drug interaction study of Ruzasvir and Bemnifosbuvir
Conditions
- Healthy Volunteer Study
Interventions
Cohort 1 BEM + RuzasvirDrug
Days 1 to 6 BEM under fasting conditions. Days 7 to 12 of BEM and Ruzasvir coadministered under fasting conditions. Days 13 to 18 of BEM and Ruzasvir coadministered under fed conditions
Cohort 2 Ruzasvir + BEMDrug
Days 1 to 6 of Ruzasvir under fasting conditions. Days 7 to 12 of Ruzasvir and BEM coadministered under fasting conditions. Days 13 to 18 of Ruzasvir and BEM coadministered under fed conditions
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetics (PK) of BEMTime frame: Days 6, 12, 18
- Pharmacokinetics (PK) of RuzasvirTime frame: Days 6, 12, 18
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Atea Study Site
Québec, Montreal, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.